Treasury

Treasury is a biotechnology company dedicated to building a universal donor stem cell registry to enable off-the-shelf regenerative medicines. The company utilizes induced pluripotent stem cell (iPSC) technology and advanced genomic screening to identify and develop cell lines that are immunologically compatible with broad patient populations. By solving the "matching" problem in cell therapy, Treasury aims to reduce costs and increase the accessibility of life-saving treatments for autoimmune disorders, cancer, and degenerative diseases. Their platform serves as a foundational infrastructure for the next generation of cell-based therapeutics. The company's approach focuses on creating a scalable solution for the global supply of high-quality, compatible stem cells.